Integrative analysis of pooled CRISPR screens provide functional insights into AD GWAS risk genes
Rebecca Y. Wang, Glenn G. Wozniak, Xiaoting WangiD, Meer MustafaiD, Malak El Khatib, Elias Kahn, Peter HeutinkiD, Hua LongiD, Sara Kenkare-Mitra, Arnon RosenthaliD, Zia KhaniD, Julia Kuhn, Daniel R. GulbransoniD
Abstract
Emerging research has implicated Alzheimers disease (AD) pathology with dysregulation of many key pathways in microglia, including lipid transport and metabolism, phagocytosis of plaques, and lysosomal function. However, the exact mechanisms underlying these pathways remain poorly understood. Leveraging high-throughput CRISPR screens to understand the interplay between these pathways may enable novel therapeutic strategies for AD and other neurological diseases. Here, we constructed activation and interference CRISPRa/i libraries targeting 203 genes, 71 of which were identified through neurodegenerative GWAS, and 132 additional genes linked to microglial functions. We used this library to conduct pooled CRISPRa/i screens across a range of functional assays relating to lipid metabolism and lysosomal function using a monocytic cell line, THP-1. We identified a core set of lipid and lysosome mediators and validated a subset in primary macrophages. To gain insights into transcriptional states modulated by these genes we also applied the CRISPRa/i libraries to Perturb-seq, enabling us to capture transcriptomic changes. Through non-negative matrix factorization, we identified five gene programs altered by our perturbation library. We then used an integrative analysis of functional screen data with Perturb-seq data that enabled us to uncover novel functions and genetic relationships between perturbations. This multidimensional resource links genetic perturbations to phenotypes and transcriptional programs, establishing a scalable framework for systematic gene discovery in neurodegeneration and beyond. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=162 SRC="FIGDIR/small/660041v1_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@5b2acborg.highwire.dtl.DTLVardef@156a0b1org.highwire.dtl.DTLVardef@4fdbb8org.highwire.dtl.DTLVardef@e2166c_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
Christopher L. Cardona, Lai Wei, … Andrew A. Sproul·Journal of NeuroinflammationPeer-reviewed·Dec 3, 2025
- A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveals modulators of memory function
Adam D. Hudgins, Shiyi Zhou, … Yousin Suh·NeuronPeer-reviewed·Apr 30, 2024
- Integrated morphological, multi-omics, and functional profiling reveals microglial plasticity driven by AD risk genes
Yingjie Zhang, Ai Zhang, … Claire G. Jeong·bioRxiv·Sep 10, 2026
- An arrayed CRISPR/Cas9 screen identifies mTORC1 as a regulator of lipid droplet accumulation in APOE E3 and APOE KO iPSC-derived microglia
Sonja Meier, Anne Sofie G. Larsen, … Ravi Jagasia·bioRxiv·Mar 16, 2024
- Systematic CRISPRi perturbation of 1,408 autism risk genes maps multilevel transcriptional convergence in human cortical neurons
Ashlesha Gogate, Wei-Chen Chen, … Maria H. Chahrour·bioRxiv·Sep 4, 2026
- Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk
Marta Perez‐Alcantara, Sam J. Washer, … Andrew Roger Bassett·bioRxiv·Aug 18, 2025